Skip to main content
. 2014 Feb 5;13:23. doi: 10.1186/1476-4598-13-23

Figure 6.

Figure 6

Tumor growth rate and weight in mice treated with chemotherapy alone or in conjunction with BLF501. Oral administration of BLF501 did not interfere with the antitumor activity of DXR. DXR-treated mice showed a reduction of body weight at the end of experiment, while a slight weight increase was observed in mice treated with DXR and BLF501. Error bars means SD Experiments were performed in triplicate.